CHICAGO — One in 285 children born in the U.S. this year alone will be diagnosed with cancer before their 20th birthday1, yet, until recently, too little was known about the genetic alterations that drive their cancers to appropriately manage the disease. To address this global issue, Thermo Fisher Scientific today announces it has established the International […]
Comprehensive circulating tumor DNA reference materialS FOR NGS assay development, validation, and daily run controls MILFORD, Mass. — SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announces two new upcoming additions to the Seraseq™ Circulating Tumor DNA (ctDNA) portfolio of reference materials, ctDNA Complete™ and ctDNA Panels. These new reference […]
Mr. Lubniewski assumes the role after having served for seven years as Chief Business Officer TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the promotion of John Lubniewski to President and Chief Operating Officer. Mr. Lubniewski has served as HTG’s chief business officer for the past […]
After the announcement of investing in 10 PacBio Sequel Systems in earlier 2018,Annoroad plans to increase its collaboration with Pacific Biosciences. The two parties plan to collaborate, based on PacBio’s SMRT® Sequencing technology, in the areas of plant & animal genome studies, basic research in human biomedical sciences and translational medicine. In 2017, Annoroad declared its […]
The Genoox Integrated Platform is Designed to Offer Solutions for Combining Genoox Technology for Aligning and Calling NGS Short-Reads with Bionano Genome Mapping Technology to Better Understand Complexities of DNA Mutations SAN FRANCISCO–Genoox, the healthcare technology company on a mission to make it easier for doctors, clinicians and researchers to run clinical genetic applications and […]
–Early access researchers will present data at the annual meeting of the American Association for Cancer Research in Chicago this week– PLEASANTON, CA.—10x Genomics, a company focused on accelerating genomic discovery, today launched the Chromium Single Cell CNV Solution, which is the first scalable and easy-to-use technology for rapid and massively parallel profiling of single cell […]
Expands Illumina’s Oncology Offerings for NextSeq™ 550Dx A Diagnostic Version of the Illumina TruSight™ Oncology 500 Assay Will Measure Potentially Predictive Genomic Biomarkers, Including Tumor Mutation Burden NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally […]
Tokyo, Japan – Hitachi High-Technologies Corporation (TSE:8036, Hitachi High-Tech) announced Hitachi High-Tech’ s capital participation in OmniSeq®,Inc. (OmniSeq), which is a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, which was the first institution to focus exclusively on cancer research. Hitachi High-Tech has made the field of biotechnology and healthcare its priority. Amid […]
Scientists in North America can now benefit from the high contrast, label-free, live cell imaging provided by Livecyte™, following the appointment of Bulldog Bio as the Phasefocus™ distributor for USA and Canada. This announcement signals the start of an exciting time for Phasefocus, as the company seeks to make headway on its initial achievements and […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ CFTR NGS Library Prep Assay, a highly efficient and scalable next-generation sequencing (NGS) library prep workflow for sequencing of the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Cystic fibrosis (CF) is a complex, multisystem disease that is caused by mutations in the […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
